Sai Life Sciences Limited (BOM:544306)
India
· Delayed Price · Currency is INR 725.55
+12.20 (1.71%)
At close: May 13, 2025
Sai Life Sciences Revenue
In the fiscal year ending March 31, 2025, Sai Life Sciences had annual revenue of 17.31B INR with 18.17% growth. Sai Life Sciences had revenue of 5.89B in the quarter ending March 31, 2025, with 33.12% growth.
Revenue
17.31B
Revenue Growth
+18.17%
P/S Ratio
8.74
Revenue / Employee
5.52M
Employees
2,845
Market Cap
151.26B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 17.31B | 2.66B | 18.17% |
| Mar 31, 2024 | 14.65B | 2.48B | 20.38% |
| Mar 31, 2023 | 12.17B | 3.48B | 39.97% |
| Mar 31, 2022 | 8.70B | 1.10B | 14.44% |
| Mar 31, 2021 | 7.60B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reliance Industries | 9,646.93B |
| HDFC Bank | 2,728.47B |
| Tata Consultancy Services | 2,553.24B |
| Bharti Airtel | 1,627.08B |
| ICICI Bank | 2,006.54B |
| State Bank of India | 3,429.39B |
| Infosys | 1,647.16B |
| Hindustan Unilever | 631.21B |